 HOUSTON, May 5, 2021 PRNewswire -- Soliton, Inc., Nasdaq: SOLY Soliton or the Company, a medical device company with a novel and proprietary aesthetic platform technology, today announced the launch of its highly anticipated Rapid Acoustic PulseTM RAP device RESONICTM. The dual-platform RESONICTM device utilizes a first-of-its-kind technology and offers a paradigm-shifting approach to two in-demand procedures: tattoo removal and cellulite treatment. 